|
|
|
| Comparative study among MRI features and risk stratification in rectal stromal tumor |
| SUN Chao1, LIU Jun2, LI Peng2, XU Liang2 |
1. Graduate School of Nankai University, Tianjin 300071, China;
2. Department of Imaging, Tianjin People’s Hospital, Tianjin 300121, China |
|
|
|
|
Abstract Objective: To summarize MRI features and investigate the relationship between MRI manifestations and risk stratification in rectal stromal tumor. Methods: Appearances of MRI in 18 cases of rectal gastrointestinal stromal tumors diagnosed by surgery and pathology between 2012 and 2016 were analyzed retrospectively, assessing tumor risk stratification. Results: Pathological classification was as following: among them, 72%(13/18) were high-risk, 22%(4/18) were intermediated-risk, 6%(1/18) were low-risk. MRI findings were graded for rectal stromal tumors by two radiologists. There was a significant correlation between certain MRI features(tumor size, boundary and uniformity of signal) and tumor risk stratification(P<0.05). However, tumor growth pattern and morphous were found to have no statistical significance for high-risk malignant rectal stromal tumor. Conclusion: Rectal stromal tumor has some specific MRI findings which could have important significances for qualitative diagnosis, assessing tumor risk stratification and differential diagnosis.
|
|
Received: 16 June 2016
|
|
|
|
|
|
[1]Valsangkar N, Sehdev A, Misra S, et al. Current management of gastrointestinal stromal tumors: surgery, current biomarkers, mutations, and therapy[J]. Surgery, 2015, 158(5): 1149-1164.
[2]Xiao CC, Zhang S, Wang MH, et al. Clinicopathological features and prognostic factors of rectal gastrointestinal stromal tumors[J]. J Gastrointest Surg, 2013, 17(4): 793-798.
[3]Yoon KJ, Kim NK, Lee KY, et al. Efficacy of imatinib mesylate neoadjuvant treatment for a locally advanced rectal gastrointestinal stromal tumor[J]. J Kor Soc Coloproctol, 2011, 27(3): 147-152.
[4]Dong C, Jun-Hui C, Xiao-Jun Y, et al. Gastrointestinal stromal tumors of the rectum: clinical, pathologic, immunohistochemical characteristics and prognostic analysis[J]. Scand J Gastroenterol, 2007, 42(10): 1221-1229.
[5]Jiang ZX, Zhang SJ, Peng WJ, et al. Rectal gastrointestinal stromal tumors: imaging features with clinical and pathological correlation[J]. World J Gastroenterol, 2013, 19(20): 3108-3116.
[6]中国CSCO胃肠间质瘤专家委员会. 中国胃肠间质瘤诊断治疗专家共识（2011年版）[J]. 临床肿瘤学杂志，2011，15（9）：836-844.
[7]Jakhetiya A, Garg PK, Prakash G, et al. Targeted therapy of gastrointestinal stromal tumors[J]. World J Gastrointest Surg, 2016, 8(5): 345-352.
[8]王庭红. MRI对直肠间质瘤的术前诊断价值[J]. 中国CT和MRI杂志，2014，12（1）：75-78.
[9]Purysko AS, Coppa CP, Kalady MF, et al. Benign and malignant tumors of the rectum and perirectal region[J]. Abdom Imaging, 2014, 39(4): 824-852.
[10]Amato A. Colorectal gastrointestinal stromal tumor[J]. Tech Coloproctol, 2010, 14(Suppl 1): S91-S95.
[11]Hou YY, Zhou Y, Lu SH, et al. Imatinib mesylate neoadjuvant treatment for rectal malignant gastrointestinal stromal tumor[J]. World J Gastroenterol, 2009, 15(15): 1910-1913. |
| [1] |
LI Xin-ming1, JIA Hong-shun1, REN Yun-yan2, SHI Da1, YAN Chao-qun1,YUAN Yang-guang1, LI Shi-si1, LIANG Wen1, QUAN Xian-yue1 . MRI diagnosis of the third ventricular masses[J]. JOURNAL OF CHINA MEDICAL IMAGING, 2017, 28(4): 229-302. |
|
|
|
|
